Kathleen D. Whitney

https://assets.montefioreeinstein.org/profiles/images/physphoto/Whitney_Kathleen_D_MD_3514.jpg

First Name

Kathleen

Last Name

Whitney

NPI

1821178328

Faculty ID

6789

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3851

Is Open Scheduling

Off

Berrin Ustun

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ustun_Berrin_MD_11119532.jpg

First Name

Berrin

Last Name

Ustun

NPI

1568789394

Faculty ID

13617

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5648

Is Open Scheduling

Off

Molly O. Regelmann

https://assets.montefioreeinstein.org/profiles/images/Regelmann_Molly_MD_2x.jpg

First Name

Molly

Last Name

Regelmann

NPI

1972761237

Faculty ID

15164

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Endocrinology

Elsevier Profile

EMR ID

73286

Biography

<p>Dr. Regelmann is an Assistant Professor of Pediatric Endocrinology and Diabetes at the Children&rsquo;s Hospital at Montefiore. She formerly held the same position at the Icahn School of Medicine at Mount Sinai, where she established herself for clinical excellence, being named a New York Rising Stars Super Doctor and Castle Connolly Top Doctor.</p><p>Dr. Regelmann graduated magna cum laude with high honors in research from Cornell University. She received her medical education at New York University. She completed residency training in general pediatrics and fellowship training in pediatric endocrinology at the Icahn School of Medicine at Mount Sinai.</p>

Is Open Scheduling

On

Jennifer M. Oliver-Krasinski

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/11db4220-42b1-11ed-ad3f-b1cabe5c6255.jpg

First Name

Jennifer

Last Name

Oliver-Krasinski

NPI

1275859209

Faculty ID

15576

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

1863

Is Open Scheduling

Off

Chuanyong Lu

https://assets.montefioreeinstein.org/profiles/images/physphoto/Lu_Chuanyong_MD_420x504.jpg

First Name

Chuanyong

Last Name

Lu

NPI

1568729085

Faculty ID

15913

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

13014

Is Open Scheduling

Off

Franklin C. Lowe

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/1c4ff810-6315-11ee-bd4e-3d8872337956.jpg

First Name

Franklin

Last Name

Lowe

NPI

1801971270

Faculty ID

14708

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Treatment of benign and malignant disorders of the prostate.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Urological topics<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

73230

Biography

<p>Franklin C. Lowe, MD, Professor of Urology and Vice-Chair of the Department, is also Director of Urologic Services, Jack D. Weiler Hospital. An expert in the treatment of benign and malignant disorders of the prostate, Dr. Lowe has published over 150 articles on multiple urological topics and has lectured extensively throughout the world. Prior to joining The Department of Urology at Montefiore, Dr. Lowe held faculty and leadership positions at Columbia University, Mount Sinai School of Medicine and at St. Luke&rsquo;s/ Roosevelt Hospital in Manhattan. A Graduate of Princeton University, Dr. Lowe obtained both his Medical and Masters of Public Health degrees from Columbia University College of Physicians and Surgeons. He completed his internship and residency in Surgery and Urology at The James Buchanan Brady Urological Institute of Johns Hopkins University. Dr. Lowe previously served as the Chairman of The American Urological Association&rsquo;s Alternative Medicine Committee and as a member of the BPH Guidelines Committee.</p>

Is Open Scheduling

On

Javier A. Laurini

https://assets.montefioreeinstein.org/profiles/images/physphoto/Laurini_Javier_420x504.jpg

First Name

Javier

Last Name

Laurini

NPI

1588723118

Faculty ID

16761

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="font-size:11.0pt;line-height:107%;font-family:'Calibri',sans-serif;">Dr. Laurini's clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the breast, gynecologic tract and bone and soft tissues.</span>

Research Focus

<span style="font-size:11.0pt;line-height:107%;font-family:'Calibri',sans-serif;">Dr. Laurini's research focus follows his clinical interests in breast and gynecologic pathology.</span>

Elsevier Profile

EMR ID

114777

Biography

<p>Javier Ariel Laurini, MD, is Associate Professor, Pathology at Montefiore Einstein. Dr. Laurini's clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the breast, gynecologic tract and bone and soft tissues.</p>

<p>After earning his Doctor of Medicine in 1995 from the University Of Salvador, School Of Medicine in Buenos Aires, Argentina, Dr. Laurini completed a residency in anatomic pathology in 1999 at the Center of Medical Education and Clinical Investigations (CEMIC) in Buenos Aires. Following this, he completed a three-month internship in hematopathology service at Massachusetts General Hospital. Dr. Laurini became Administrative Chief Resident in the department of pathology at CEMIC for one year before completing a surgical pathology fellowship at British Hospital in Buenos Aires in 2002. He then became a visiting clinician in the Department of Pathology, Mayo Clinic in Rochester before undergoing a combined anatomic and clinical pathology residency at the University of South Alabama College of Medicine, which he completed in 2010. Dr. Laurini then finished a fellowship in surgical pathology at the Mayo Clinic in 2011 before completing another fellowship in hematopathology at the University of Nebraska Medical Center in 2012.</p>

<p>Dr. Laurini's research focus follows his clinical interests in breast and gynecologic pathology. His work has been published in numerous original communications and peer-reviewed journals, articles and abstracts.</p>

<p>Dr. Laurini is board certified in Hematology and Anatomic and Clinical Pathology by the American Board Of Pathology. He is a Fellow of the College of American Pathologists and the American Society of Clinical Pathologists, and a member of the United States and Canadian Academy of Pathology. He is also part of the Mayo Clinic Alumni Association. Dr. Laurini has won multiple faculty teaching awards from the University of South Alabama and Wake Forest School of Medicine. In 2022 he won the Attending Teaching Award from Einstein.</p>

Is Open Scheduling

Off

Rouzan G. Karabakhtsian

https://assets.montefioreeinstein.org/profiles/images/physphoto/Karabakhtsian_Rouzan_MD_420x504.jpg

First Name

Rouzan

Last Name

Karabakhtsian

NPI

1881624963

Faculty ID

14851

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4629

Is Open Scheduling

Off

Laura J. Hodges

https://assets.montefioreeinstein.org/profiles/images/physphoto/Hodges_Laura_MD_420x504.jpg

First Name

Laura

Last Name

Hodges

NPI

1831147438

Faculty ID

16292

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Women&rsquo;s interventional procedures, specifically uterine artery embolization for fibroid disease.

Research Focus

Women&rsquo;s interventional procedures, specifically uterine artery embolization for fibroid disease.

Elsevier Profile

EMR ID

11807

Biography

<p>Laura J. Hodges, MD, is Attending Physician at Montefiore and Assistant Professor of Radiology at our Albert Einstein College of Medicine. Her practice specialty is breast imaging and interventional radiology, with a clinical focus on women&rsquo;s interventional procedures, specifically uterine artery embolization for fibroid disease.</p><p>After receiving her Bachelor of Arts from University of Connecticut in 1985 and her Bachelor of Science from George Washington University in 1987, Dr. Hodges earned her Doctor of Medicine at Albert Einstein College of Medicine in 1994. Upon graduation, she then pursued postdoctoral training at Yale New Haven Hospital, completing a Radiology residency in 1999. She then attended Cornell Medical Center/Sloan Kettering Memorial Cancer Center where she completed a fellowship in Interventional Radiology in 2000.</p><p>Dr. Hodges&rsquo;s research interests build on her clinical focus. She has published a case study on preoperative transcatheter embolization of abdominal pregnancy, as well as a number of abstracts on women&rsquo;s interventional procedures.</p><p>Dr. Hodges is board certified and is a member of several professional societies, including the Society of Interventional Radiology, the American College of Radiology and the American Roentgen Ray Society.</p>

Is Open Scheduling

Off

Susan A. Fineberg

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2851b8d0-d526-11eb-af57-a79c115e5bbd.jpg

First Name

Susan

Last Name

Fineberg

NPI

1942380449

Faculty ID

5173

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr Fineberg's clinical focus is on the study of breast disease both neoplastic and benign.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Fineberg's research focus is on the development of new predictive and prognostic biomarkers to be used in breast cancer patients to optimize clinical outcomes, investigation of the role of immunotherapy and standardization of pathologic practices amongst breast pathologists.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p>Lanjewar S, Patil P, <strong>Fineberg S. </strong>Pathologic reporting practices for breast cancer specimens after neoadjuvant chemotherapy- A survey of pathologists in academic institutions across the United States. Modern Pathol. 2019 .(33), 91-98. <a title="Read article" href="https://doi.org/10.1038/s41379-019-0326-5&quot; target="_blank">https://doi.org/10.1038/s41379-019-0326-5</a></p&gt;
<p>Kimberly J. Van Zee, MS, MD, Emily C. Zabor, MS, Rosemarie Di Donato, MD3, Bryan Harmon, MD, Jana Fox, MD, Monica Morrow, MD, Hiram S. Cody III, MD, <strong>Susan A. Fineberg, MD. </strong>A Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Vs Refined Oncotype DX Breast DCIS Score. Annals of Sugical Oncology . 2019 (26), 212-213. <a title="Read article" href="https://doi.org/10.1245/s10434-019-07537-4&quot; target="_blank">https://doi.org/10.1245/s10434-019-07537-4</a></p&gt;
<p>Didonato R, Shapiro N, Koenigsberg, D&acirc;&euro;&trade;Alfonso, T, Jaffer S, <strong>Fineberg S</strong>. Invasive Mucinous Carcinoma of the breast and Response Patterns After Neodjuvant Chemotherapy. Histopathology 2018 May; 72(6):965-973</p>
<p>Hazan, R, Suyamaa, K, Yao J, Liang H, Bernard , Loudig O Amgalm D, Mckimplson W, Phillops G, Segall J, Wang Y, <strong>Fineberg S,</strong> Norton L, Kitsis R. A paradoxical role for an Akt3 splice variant lacking serine 472 phosphorylation site in promoting apoptosis leading to suppression of mammary tumorigenesis. Cancer Research. 2018:78(1).103-114</p>
<p>Pearlman A, Upadhyay K, Cole K, Loke J, Suan K, <strong>Fineberg S,</strong> Freedland S, Shao Y, Ostrer H. Robust genomic copy number predictor of pan cancer metastasis. Genes and Cancer. 2018 <a title="Read article" href="https://doi.org/10.18632/genesandcancer.165&quot; target="_blank">https://doi.org/10.18632/genesandcancer.165</a></p&gt;
<p>Guo Tianhua, Shapiro Nella, Wang Yihong, <strong>Fineberg Susan</strong>. Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: Clinicopathologic features and correlation with subsequent excision.Clinical Breast Cancer 2018 (4) e449-454 DOI: /10.1016/j.clbc.2017.10.004</p>
<p>Mclemore L Janakiram M, Albanese J, Shapiro N, Lo Y, Zang X, <strong>Fineberg S.</strong> An immunoscore using PD-L1, CD68 and tumor infiltrating lymphocytes (TILs) to predict response to neoadjuvant chemotherapy in invasive breast cancer. Appl Immunohistochem Mol Morphol.2018;26(9), 611-619. doi: 10.1097/PAI.0000000000000485</p>
<p>Maria-Vittoria Dieci, Nina Radosevic-Robin, <strong>Susan Fineberg</strong> et. al., on behalf of the International Immuno-Oncology Bio-marker Working Group* Update on Tumor Infiltrating Lymphocytes (TILs) in Breast Cancer, including recommendations to assess TILs in Residual Disease and DCIS: a report of the International Immuno-Oncology Biomarker Working group on Breast Cancer*. Seminars in Cancer Biology 2107:52.16-25. <a title="Persistent link using digital object identifier" href="https://doi.org/10.1016/j.semcancer.2017.10.003&quot; target="_blank">https://doi.org/10.1016/j.semcancer.2017.10.003</a></p&gt;
<p>Mantilla JG, Koenigsberg T, Reig B, Shapiro N, Villaneuva-Siles E, <strong>Fineberg S.</strong> Core biopsy of vascular neoplasms of the breast; Pathologic features , imaging and clinical findings. Amer J of Surg Pathol .2016; 40:1424-1434</p>
<p>Polley M, Leung S, Gao D, Mastropasqua M, Zabaglo L, Bartlett J, McShane L, Enos R, Badve S, Bane A, Borgquist S, <strong>Fineberg S</strong>, Lin M, Grabau A, Gutierrez C, Hugh J, Moriya T, Ohi Y, Osborne K, Penault-Llorca F, Piper T, Porter P, Sakatani T, Salgado R, Starczynski J, L&Atilde;&brvbar;nkholm A, Viale G, Dowsett M, Hayes D, Nielsen T, on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG). An international study to increase concordance in Ki67 scoring. Modern Pathology .2015; 28 (6) :778. PubMed [citation] PMID 25698062</p>
<p>Diaz J, Stead L, Shapiro N, Newell R, Loudig O, Lo Y, Sparano J, <strong>Fineberg S</strong>. Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease. Breast Cancer Research and Treatment. 2013; 138 :91-97. PubMed [citation] PMID 23417359</p>
<p>Giricz, O, Reynolds P, Rammuauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro, N <strong>, Fineberg S,</strong> Kenny P, Loudig O. Has-miR375 is differentially expressed during lobular neoplasia and promotes loss of mammary acinar polarity. Journal of Pathology. 2012; 226 (1): 108-119 .PubMed [citation] PMID 21953071</p>
<p>Auerbach J, Kim M, <strong>Fineberg S</strong>. Can results of routine pathologic evaluation of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX Assay Recurrence Score result? Archives of Pathology and Laboratory Medicine. 2010; 134, (11): 1697-1701. PubMed [citation] PMID 21043825</p>
<p>Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, deng HF, Ament PS, <strong>Fineberg S,</strong> Pestell RG, Carasco N. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature Medicine .2000; 6 (8): 871-878. PubMed [citation] PMID: 10932223</p>
<p>Casey M, Zimmerman J, Rosenblatt R, <strong>Fineberg S.</strong> Mastectomy without malignancy following carcinoma diagnosed by large core stereotactic breast biopsy. Modern Pathology.1997; 10 (12): 1209-1213. PubMed [citation] PMID: 9436965</p>
<p><strong>Fineberg S</strong>, Rosen P. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. Am J Clin Pathol. 1994; 102 (6): 757-762. PubMed [citation] PMID: 7801888</p>

EMR ID

3791

Biography

<p>Susan Fineberg, MD, is an Attending Pathologist, Section Head Breast Pathology and Associate Professor, Pathology at Montefiore Einstein. An integral member of the multidisciplinary breast program leadership team, Dr. Fineberg&rsquo;s clinical focus is the study of tissue to diagnose breast disease, both neoplastic and benign.</p><p>After receiving her Bachelor of Arts in chemistry from State University of New York (SUNY) Binghamton in 1983, Dr. Fineberg pursued her medical degree at SUNY Stonybrook School of Medicine, earning her Doctor of Medicine in 1987. She completed her anatomic and clinical pathology residency training at New York University Medical Center in 1992, followed by an oncologic surgical pathology fellowship at Memorial Sloan Kettering Cancer Center in 1993.</p><p>Dr. Fineberg's research focus includes biomarker development in invasive breast cancer, particularly in the neoadjuvant setting, prognostic and predictive markers for ductal carcinoma in situ progression and recurrence, the role of immune response in breast cancer progression, and standardization of practice among breast pathologists. She has over 60 peer-reviewed publications on breast disease, has authored book chapters on the subject and has presented her work at national meetings.</p><p>Dr. Fineberg is board certified and is an active member of many national and international pathology organizations including the United States and Canadian Academy of Pathology, the International Society of Breast Disease and the International TILs Immuno-Oncology Biomarker Working Group for Breast Cancer.</p>

Is Open Scheduling

Off